. Author manuscript; available in PMC: 2019 Apr 1.

Published in final edited form as: Med Decis Making. 2018 Apr;38(1 Suppl):126S–139S. doi: 10.1177/0272989X17729358

Table 4.

Changes in DCIS detection and overdiagnosis of DCIS when moving from biennial 50-74 years to other screening scenarios.

change in DCIS detection

change in DCIS overdiagnosis

\frac{change in DCIS overdx}{change in DCIS detection}

Model

A50-74

B40-74

B50-84

A50-74

B40-74

B50-84

A50-74

B40-74

B50-84

0.1

0.0

2.8

0.1

2.8

100%

N/A

100%

8.5

4.8

5.6

6.7

3.3

5.2

79%

69%

93%

3.2

3.6

6.3

0.4

1.2

3.0

13%

33%

48%

13.6

5.0

5.5

13.7

5.1

5.6

101%

102%

14.0

2.4

9.7

7.1

1.5

-1.1

51%

63%

-11%

A50-74: annual screening from age 50-74 years.

B40-74: biennial screening from age 40-74 years.

B50-84: biennial screening from age 50-84 years.

Model D: Dana-Farber Cancer Institute, Boston, Massachusetts. Model E: Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. Model GE: Georgetown University Medical Center, Washington, DC, and Albert Einstein College of Medicine, Bronx, New York. Model M: MD Anderson Cancer Center, Houston, Texas. Model W: University of Wisconsin-Madison, Madison, Wisconsin, and Harvard Medical School, Boston, Massachusetts.